Cargando…

Prevention and treatment of ventilator-associated pneumonia in COVID-19

Ventilator-associated pneumonia (VAP) is the most common acquired infection in the intensive care unit. Recent studies showed that the critical COVID-19 patients with invasive mechanical ventilation have a high risk of developing VAP, which result in a worse outcome and an increasing economic burden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Jiayi, Li, Fanglin, Zhang, Ningjie, Zhong, Yanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627032/ https://www.ncbi.nlm.nih.gov/pubmed/36339583 http://dx.doi.org/10.3389/fphar.2022.945892

Ejemplares similares

Risk Factors of Ventilator-Associated Pneumonia in Critically III Patients
por: Wu, Diling, et al.
Publicado: (2019)

Drug Prevention and Control of Ventilator-Associated Pneumonia
por: Xie, Xinming, et al.
Publicado: (2019)

Probiotics for Preventing Ventilator-Associated Pneumonia in Mechanically Ventilated Patients: A Meta-Analysis with Trial Sequential Analysis
por: Weng, Hong, et al.
Publicado: (2017)

The Role of High-Density Lipoprotein in COVID-19
por: Wang, Guyi, et al.
Publicado: (2021)

Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment
por: Li, Hong-Yan, et al.
Publicado: (2022)

The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy
por: Wang, Guyi, et al.
Publicado: (2022)

Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia
por: Shen, Shan, et al.
Publicado: (2022)

Effects of Gastric Acid Secretion Inhibitors for Ventilator-Associated Pneumonia
por: Li, Fang, et al.
Publicado: (2022)

The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database
por: Yang, Rui, et al.
Publicado: (2022)

The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
por: Wang, Chao-Yang, et al.
Publicado: (2019)

Viral-Reactivated Pneumonia during Mechanical Ventilation: Is There Need for Antiviral Treatment?
por: López-Giraldo, Alejandra, et al.
Publicado: (2011)

Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov
por: Chen, Lingmin, et al.
Publicado: (2019)

Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae
por: Gao, Bo, et al.
Publicado: (2019)

COVID-19-Associated Pneumonia: Radiobiological Insights
por: François, Sabine, et al.
Publicado: (2021)

Using Restricted Cubic Splines to Study the Duration of Antibiotic Use in the Prognosis of Ventilator-Associated Pneumonia
por: Xu, Yixian, et al.
Publicado: (2022)

Acinetobacter baumannii Ventilator-Associated Pneumonia: Clinical Efficacy of Combined Antimicrobial Therapy and in vitro Drug Sensitivity Test Results
por: Huang, Yuqin, et al.
Publicado: (2019)

The Association Between Bronchoscopy and the Prognoses of Patients With Ventilator-Associated Pneumonia in Intensive Care Units: A Retrospective Study Based on the MIMIC-IV Database
por: Zhang, Luming, et al.
Publicado: (2022)

ZBP1 and heatstroke
por: Li, Fanglin, et al.
Publicado: (2023)

The Association Between Alveolar–Arterial Oxygen Tension Difference and the Severity of COVID-19 in Patients
por: Xie, Canbin, et al.
Publicado: (2023)

Effect of Stress Ulcers Prophylaxis, Sedative and Statin on Ventilator-Associated Pneumonia: A Retrospective Analysis Based on MIMIC Database
por: Kong, Xuetao, et al.
Publicado: (2022)

Thiamine May Be Beneficial for Patients With Ventilator-Associated Pneumonia in the Intensive Care Unit: A Retrospective Study Based on the MIMIC-IV Database
por: Zhang, Luming, et al.
Publicado: (2022)

Trends and Development in Enteral Nutrition Application for Ventilator Associated Pneumonia: A Scientometric Research Study (1996–2018)
por: Chen, Shengqi, et al.
Publicado: (2019)

Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model
por: Aguiar-Alves, Fábio, et al.
Publicado: (2022)

Clinical Efficacy and In Vitro Drug Sensitivity Test Results of Azithromycin Combined With Other Antimicrobial Therapies in the Treatment of MDR P. aeruginosa Ventilator-Associated Pneumonia
por: Huang, Yuqin, et al.
Publicado: (2022)

Pulmonary fibrosis in patients with COVID-19: A retrospective study
por: Li, Fanglin, et al.
Publicado: (2022)

Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
por: Wu, Ying, et al.
Publicado: (2021)

Commentary: Trends and Development in Enteral Nutrition Application for Ventilator Associated Pneumonia: A Scientometric Research Study (1996–2018)
por: Ho, Yuh-Shan
Publicado: (2019)

Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: An evidence mapping study
por: Li, Yanfei, et al.
Publicado: (2023)

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience
por: Shi, Rupeng, et al.
Publicado: (2023)

High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study
por: Zhao, Bing, et al.
Publicado: (2021)

Prevention of ventilator-associated pneumonia in adults
por: Prescott, Hallie C, et al.
Publicado: (2010)

Toothbrushing for preventing ventilator-associated pneumonia
por: Labeau, Sonia O, et al.
Publicado: (2013)

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
por: Wu, Zhenping, et al.
Publicado: (2023)

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022)

Associations Between Antithrombosis and Ventilator-Associated Events, ICU Stays, and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
por: Wang, Mingqi, et al.
Publicado: (2022)

The paradox of ventilator-associated pneumonia prevention measures
por: Klompas, Michael
Publicado: (2009)

Novel preventive strategies for ventilator-associated pneumonia
por: Coppadoro, Andrea, et al.
Publicado: (2012)

Edible and Herbal Plants for the Prevention and Management of COVID-19
por: Li, Sha, et al.
Publicado: (2021)

Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022)

COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia
por: Póvoa, Helvécio Cardoso Corrêa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ivtqmp60abbcbjfbno7obkk920